Hypermobile Ehlers-danlos Syndrome
📧 Sign up to get email alerts when something new happens for Hypermobile Ehlers-danlos Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation [NA]
A clinical trial evaluating transcutaneous auricular neuromodulation for Hypermobile Ehlers-Danlos syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Identifying the Determinants of Bleeding and Hypermobility in Patients With Heavy Menstrual Bleeding
A terminated clinical trial investigated determinants of bleeding and hypermobility in patients with heavy menstrual bleeding.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Oxytocin for Hypermobile Ehlers-Danlos Syndrome [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating oxytocin for Hypermobile Ehlers-Danlos Syndrome has been terminated; results were posted on 2025-08-28…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Online Pilates Exercise for People With Hypermobility [NA]
The online Pilates exercise trial for hypermobility conditions has completed. The study was sponsored by Clarkson University.
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Dyspnea in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder [NA]
The trial evaluating dyspnea in Hypermobile Ehlers-Danlos syndrome and Hypermobility Spectrum Disorder has completed. No efficacy results or…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.